Strong diabetes

British Journal of Sports Medicine

Volumn 41, Issue 5, 2007, Pages 335-336

  Young, James ^a,b   Anwar, Aresh ^a  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^b 2 Rectory Farm Barns ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; GLUCOSE; GROWTH HORMONE; INSULIN;

ACUTE KIDNEY FAILURE; ADULT; ANAMNESIS; ARTICLE; ATHLETE; BODY BUILDING; CASE REPORT; CLINICAL FEATURE; CRYSTALLOID; DIABETES MELLITUS; DRUG MISUSE; EMERGENCY WARD; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEPATITIS; HEPATOMEGALY; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; SEROLOGY; TREATMENT OUTCOME;

ADULT; ANABOLIC AGENTS; DIABETIC NEPHROPATHIES; GROWTH HORMONE; HUMANS; HYPERGLYCEMIA; INSULIN; ISOTONIC SOLUTIONS; KIDNEY FAILURE, ACUTE; MALE; TREATMENT OUTCOME; WEIGHT LIFTING;

EID: 34247887337     PISSN: 03063674     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjsm.2006.030585     Document Type: Article

References (10)

1. Cotlar MJ. Androgen-androgenic steroids, the athlete, and mortality. J Insur Med 2001;33:251-6.
2. Jorgensen JO, Norrelund H, Conceicao F, et al. Somatropin and glucose homeostasis: considerations for patient management. Treat Endocrinol 2002;1:229-34.
3. Evans PJ, Lynch RM. Insulin as a drug of abuse in body building. Br J Sports Med 2003;37:356-7.
4. Banadonna RC, Saccomani MP, Cobelli C, et al. Effect of insulin on system A amino acid transport in human skeletal muscle. J Clin Invest 1993;91:514-21.
5. International Olympic Committee and Medical Commission. Olympic movement anti-doping code. Prohibited classes of substances and prohibited methods 2001-2002.
6. McHugh CM, Park RT, Sonksen PH, et al. Challenges in detecting the abuse of growth hormone in sport. Clin Chem 2005;51:1587-93.
7. Hadzovic A, Nakas-Icindic E, Kucukalic-Selimovic E, et al. Growth hormone (GH): usage and abuse. Bosn J Basic Med Sci 2004;4:66-70.
8. Berggren A, Ehrnborg C, Rosen T, et al. Short-term administration of supraphysiological recombinant human growth hormone (GH) does not increase maximum endurance exercise capacity in healthy, active young men and women with normal GH-insulin-like growth factor I axis. J Clin Endocrinology Metab 2005;90:3268-73, Epub 22 March 2005.
9. Healy M, Gibney J, Pentecost C, et al. Effects of high dose growth hormone on glucose and glycerol metabolism at rest and during exercise in endurance-trained athletes. J Clin Endocrinol Metab 2006;91:320-7.
10. Healy ML, Gibney J, Russell-Jones DL, et al. High dose growth hormone exerts an anabolic effect at rest and during exercise in endurance-trained athletes. J Clin Endocrinol Metab 2003;88:5221- 6.